Contact
The Advanced Medical Solutions Sector is engaged in leading-edge medicines CDMO (Contract Development and Manufacturing Organization) business, including long-chain oligonucleotides, regenerative medicine and cell therapies, small molecule drugs. We are also engaged in research and development of regenerative medicine and cell therapies. Through these solutions and products, we aim to meet a diverse range of medical and healthcare needs, contributing to healthier and more fulfilling lives.
Main Products
Pharmaceutical Chemicals
-
Active pharmaceutical ingredients
We engage in the manufacture and sale of APIs and intermediates outsourced from pharmaceutical companies, as well as pharmaceutical chemical products developed in-house, such as generic APIs, based on our advanced organic synthesis technologies and quality assurance capabilities. Nucleic acid medicines are next-generation pharmaceuticals, utilizing functions of oligonucleotides which act on genes and proteins that cause disease. We undertakes contract manufacturing for oligonucleotide APIs for pharmaceutical companies.
-
Okayama Works
The Okayama works manufactures mainly pharmaceutical chemicals while also producing a variety of specialty fine chemicals. It can flexibly handle everything from batch production for the development phase to a large-scale production, and has the capabilities to scale production in response to the diversified needs of customers.
-
Gifu Works
The Gifu works manufactures a variety of specialty fine chemicals while producing mainly pharmaceutical chemicals. Responding to the growing demand for more advanced quality control, the works has been increasing the proportion of high value-added products it manufactures using its proprietary production and new synthesis methods.
-
Advanced Medical Solutions Research Laboratory
Advanced Medical Solutions Research Laboratory
In order to meet diverse medical and healthcare needs and to contribute to healthier and more prosperous lives for all people, the Advanced Medical Solutions Research Laboratory is committed to developing efficient synthetic processes and reliable analytical technologies for pharmaceutical chemicals, based on the organic chemistry and analytical chemistry expertise it has cultivated over many years. Our aim is to provide sustainable and innovative solutions for the diversifying pharmaceutical modalities, including small molecules and oligonucleotides, to customers around the world.
-
S-RACMO Co., Ltd.
S-RACMO Co., Ltd.
S-RACMO is a joint venture company established by Sumitomo Chemical and Sumitomo Pharma, providing CDMO (Contract Development and Manufacturing Organization) services for regenerative and cellular medicines. S-RACMO combines Sumitomo Chemical's base technologies for iPS/ES cells and know-how in contract manufacturing of pharmaceuticals, with Sumitomo Pharma's advanced expertise in process development, formulation development and regulatory affairs cultivated in the regenerative and cell medicine business.
The company is capable of manufacturing a wide range of regenerative and cellular medicines based on cutting-edge technology and know-how, and also continuously supports regulatory compliance including approval process.
By broadly supporting the manufacturing and process development of the customers' innovative products, S-RACMO aims to contribute to the penetration and spread of regenerative medicine products in Japan and globally.
Sumika Chemical Analysis Service, Ltd.
We provide highly reliable data that help you solve your issues that have arisen at each stage of research and development, application, manufacturing, and marketing of pharmaceuticals and other life science-related products as well as various materials including semiconductor devices, by utilizing the advanced evaluation technologies and cutting-edge analysis equipment.
Koei Chemical Co., Ltd.
Koei Chemical is a manufacturer of nitrogen-containing compounds such as pyridines, pyrazines and amines, we also supply synthesis products such as pharmaceutical and agrochemical intermediates, organometallic catalysts and optical material products, as well as functional products including ionic liquids. Our products are used in a wide variety of applications including pharmaceuticals, agrochemicals, electronic related materials, CO2 emission reduction and automotive applications, and are used in a wide range of situations throughout society.
We contribute to the realization of a sustainable society as a solution provider that offers solutions to our customers' needs by leveraging our technical capabilities based on organic synthesis over 100 years.
-
RACTHERA Co., Ltd.
RACTHERA Co., Ltd.
RACTHERA is a joint venture established by Sumitomo Chemical and Sumitomo Pharma to advance regenerative and cellular medicine business. By integrating Sumitomo Chemical's expertise in industrialization, analytical and quality control technologies with Sumitomo Pharma's pioneering knowledge and experience in regenerative medicine product development, RACTHERA aims to accelerate the research, development, and commercialization in this field.
Additionally, RACTHERA is dedicated to spearheading the growth of this business within the Sumitomo Chemical Group by acting as the central hub for research and development, in close collaboration with Sumitomo Chemical, Sumitomo Pharma, and S-RACMO, which specializes in contract manufacturing and process development. Our ultimate aim is to swiftly provide patients with innovative treatment options.
